advanced search

Amiko

Amiko provides hardware-enabled, AI-powered digital medicines. Its first product, Respiro, a digital medicine platform that combines connected inhaler sensors, apps, and data analytics to upgrade respiratory care, has been used in clinical studies and more than 30 commercial programmes across Europe.


Visit Website

Headquarters
Amiko
Piazzale Aquileja 6
20144 Milan
Italy

Connect

Amiko is an AI and advanced data analytics company that provides Respiro, a digital medicine platform that combines connected inhaler sensors, apps, and data analytics to upgrade respiratory care. Respiro is a certified medical device and has been used in clinical studies and more than 30 commercial programmes across Europe. The system delivered consistent improvements in treatment adherence and outcomes: 37% increase in medication adherence, 42% improvement in optimal inhaler technique, and a 67% reduction in reliever medication use. Amiko serves patients, healthcare providers and pharmaceutical companies. The company is ISO 13485:2016 certified and has locations in the UK and Italy.

0

SHARE

Articles by Amiko

CONNECTIVITY
Mauro Citterio
RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO
Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.
CONNECTIVITY
Martijn Grinovero
UPGRADING RESPIRATORY CARE WITH AI-POWERED SENSORS AND TRUE ADHERENCE DATA
Martijn Grinovero and Fabian Schütte describe the potential of artificial intelligence-powered sensors used in combination with standard inhalers to upgrade respiratory therapy.
Top